Cargando…
Clinical exome sequencing in France and Quebec: what are the challenges? What does the future hold?
BACKGROUND: The decreasing cost of next-generation sequencing technologies (NGS) has resulted in their increased use in research, and in the clinic. However, France and Quebec have not yet implemented nation-wide personalized medicine programs using NGS. To produce policies on the large-scale implem...
Autores principales: | Bertier, Gabrielle, Joly, Yann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068066/ https://www.ncbi.nlm.nih.gov/pubmed/30066179 http://dx.doi.org/10.1186/s40504-018-0081-2 |
Ejemplares similares
-
Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users’ views
por: Bertier, Gabrielle, et al.
Publicado: (2016) -
What does the future hold?
por: de Campos, Fernando Peixoto Ferraz
Publicado: (2012) -
What does the future hold for clinical microbiology?
por: Raoult, Didier, et al.
Publicado: (2004) -
Thyromimetics: What does the future hold?
por: Unnikrishnan, A. G., et al.
Publicado: (2012) -
Diabetic nephropathy: What does the future hold?
por: Montero, R. M., et al.
Publicado: (2015)